Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Mobile Geriatric Teams: Patient Safety and Healthcare Utilization (MGT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03662945
Recruitment Status : Completed
First Posted : September 10, 2018
Last Update Posted : September 11, 2018
Sponsor:
Collaborator:
Region Jönköping County
Information provided by (Responsible Party):
Sofi Fristedt, Jonkoping University

Brief Summary:

Objective To perform a prospective, controlled and randomized evaluation of the effectiveness of Mobile Geriatric Teams (MGT).

Method Community-dwelling, frail elderly people were randomized to intervention group (n=31, mean age 84) and control group (n=31, mean age 86). Two-year retrospective data and prospective one-year follow up, were analyzed using non-parametric and difference-in-difference (DiD) analyses. Qualitative interviews, were analyzed using content analysis.


Condition or disease Intervention/treatment Phase
Frail Elderly Syndrome Other: Mobile Geriatric Team intervention Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 62 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: 1 intervention group and 1 control group
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Mobile Geriatric Teams: A Cost-effective Way of Improving Patient Safety and Reducing Traditional Healthcare Utilization Among the Frail Elderly?
Actual Study Start Date : March 1, 2015
Actual Primary Completion Date : December 20, 2015
Actual Study Completion Date : December 20, 2015

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Intervention group
Mobile Geriatric Team intervention including physicians and nurses with the aim of developing person-centered, safe, sustainable and coordinated care plans. These care plans are developed in collaboration with the patient, his/her relatives and staff from the municipality. Among the main ambitions of this concept are improved communication flows between patients, their relatives and healthcare providers in combination with the delivery of medical as well as care measures. Other ambitions are to avoid unnecessary traditional healthcare utilization in the form of inpatient care and EMR visits, for example.
Other: Mobile Geriatric Team intervention
Person-centred intervention based on Comprehensive Geriatric Assessment

No Intervention: Control group
Standard care including primary care units, home care and home help.



Primary Outcome Measures :
  1. Health care utilization including EMR, hospital admissions, care days, out patient hospital or primary care [ Time Frame: Change from 1 year before inclusion to 1 year follow up ]
    No. of EMR visits, Out patient visits to hospital, Hospital admissions, Care days, Primary care visits


Secondary Outcome Measures :
  1. Health care utilization including EMR, hospital admissions, care days, out patient hospital or primary care [ Time Frame: Change from 2 year before inclusion to 1 year follow up ]
    No. of EMR visits, Out patient visits to hospital, Hospital admissions, Care days, Primary care visits

  2. Health care utilization including EMR, hospital admissions, care days, out patient hospital or primary care [ Time Frame: Change from inclusion to 3 year follow up ]
    No. of EMR visits, Out patient visits to hospital, Hospital admissions, Care days, Primary care visits


Other Outcome Measures:
  1. Patient and next-of-kin satisfaction assessed by Qualitative interviews [ Time Frame: Changes from inclusion to 15 week follow-up ]
    Qualitative interviews on patient safety and patient /next-of-kin satisfaction



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   75 Years and older   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

The inclusion criteria for this trial were the "frail elderly" defined as:

  • community-dwelling persons aged > 75 years,
  • having more than three chronic diagnoses,
  • prescribed six or more pharmaceutical drugs for continuous use and
  • with at least three hospital stays (> 24 hours in hospital) during the last six months.

Since these criteria were broad in order to capture relevant individuals, but also likely to generate persons of no relevance to the MGT intervention, identification of the study sample was conducted in three steps, in turn, repeated in three waves.

Exclusion Criteria:

  • Persons not able to take part in qualitative interviews

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03662945


Sponsors and Collaborators
Jonkoping University
Region Jönköping County
Investigators
Layout table for investigator information
Principal Investigator: Sofi Fristedt, Ph D Jonkoping University
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Sofi Fristedt, Ph D, Senior lecturer, Jonkoping University
ClinicalTrials.gov Identifier: NCT03662945    
Other Study ID Numbers: MGT FUTURUM-521121
First Posted: September 10, 2018    Key Record Dates
Last Update Posted: September 11, 2018
Last Verified: September 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No